11-71464130-G-T
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 3P and 2B. PS1_ModeratePP3BP4_Moderate
The NM_018161.5(NADSYN1):c.395G>T(p.Trp132Leu) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000122 in 1,609,672 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another nucleotide change resulting in same amino acid change has been previously reported as Likely pathogenicin UniProt.
Frequency
Consequence
NM_018161.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
NADSYN1 | NM_018161.5 | c.395G>T | p.Trp132Leu | missense_variant | 5/21 | ENST00000319023.7 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
NADSYN1 | ENST00000319023.7 | c.395G>T | p.Trp132Leu | missense_variant | 5/21 | 1 | NM_018161.5 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000171 AC: 26AN: 152244Hom.: 1 Cov.: 32
GnomAD3 exomes AF: 0.000513 AC: 124AN: 241556Hom.: 1 AF XY: 0.000421 AC XY: 55AN XY: 130646
GnomAD4 exome AF: 0.000117 AC: 170AN: 1457310Hom.: 1 Cov.: 30 AF XY: 0.000116 AC XY: 84AN XY: 724412
GnomAD4 genome AF: 0.000171 AC: 26AN: 152362Hom.: 1 Cov.: 32 AF XY: 0.000201 AC XY: 15AN XY: 74518
ClinVar
Submissions by phenotype
Congenital NAD deficiency disorder Pathogenic:1
Pathogenic, no assertion criteria provided | research | Embryology Laboratory, Victor Chang Cardiac Research Institute | Dec 01, 2019 | This variant, c.395G>T, was found in compound heterozygosity with the pathogenic variant c.145T>C - |
NADSYN1-related disorder Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | Mar 06, 2023 | The NADSYN1 c.395G>T variant is predicted to result in the amino acid substitution p.Trp132Leu. This variant has been reported in the compound heterozygous state in an individual with NAD deficiency (Szot et al. 2020. PubMed ID: 31883644). Functional assays in this same report showed that the p.Trp132Leu substitution causes a decrease in enzymatic activity of the protein (Szot et al. 2020. PubMed ID: 31883644). This variant is reported in 0.32% of alleles in individuals of Latino descent in gnomAD (http://gnomad.broadinstitute.org/variant/11-71175176-G-T). Although we suspect that this variant may be pathogenic, at this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Dec 04, 2023 | Published functional studies demonstrate a damaging effect with reduced protein expression and activity (PMID: 31883644); Observed with a variant on the opposite allele (in trans) in a patient in published literature (PMID: 35491967); Observed with a variant on the opposite allele (in trans) in a fetus in published literature (PMID: 31883644); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 35491967, 31883644, 36951206, 37300479) - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at